McAdam LLC’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$267K Buy
600
+84
+16% +$37.4K 0.01% 312
2025
Q1
$250K Sell
516
-1,679
-76% -$814K 0.02% 288
2024
Q4
$884K Sell
2,195
-441
-17% -$178K 0.05% 146
2024
Q3
$1.23M Buy
2,636
+116
+5% +$53.9K 0.07% 118
2024
Q2
$1.18M Buy
2,520
+488
+24% +$229K 0.07% 109
2024
Q1
$849K Buy
2,032
+35
+2% +$14.6K 0.05% 127
2023
Q4
$813K Sell
1,997
-170
-8% -$69.2K 0.06% 123
2023
Q3
$754K Buy
2,167
+4
+0.2% +$1.39K 0.06% 130
2023
Q2
$761K Sell
2,163
-60
-3% -$21.1K 0.06% 126
2023
Q1
$700K Sell
2,223
-731
-25% -$230K 0.06% 128
2022
Q4
$649K Buy
2,954
+186
+7% +$40.9K 0.06% 92
2022
Q3
$801K Buy
2,768
+5
+0.2% +$1.45K 0.09% 106
2022
Q2
$779K Sell
2,763
-170
-6% -$47.9K 0.08% 108
2022
Q1
$765K Sell
2,933
-21
-0.7% -$5.48K 0.07% 91
2021
Q4
$649K Sell
2,954
-385
-12% -$84.6K 0.06% 92
2021
Q3
$606K Buy
3,339
+1,419
+74% +$258K 0.07% 88
2021
Q2
$385K Buy
1,920
+210
+12% +$42.1K 0.04% 115
2021
Q1
$367K Hold
1,710
0.05% 106
2020
Q4
$401K Buy
1,710
+679
+66% +$159K 0.06% 99
2020
Q3
$281K Buy
1,031
+10
+1% +$2.73K 0.05% 104
2020
Q2
$296K Sell
1,021
-34
-3% -$9.86K 0.06% 88
2020
Q1
$251K Buy
1,055
+34
+3% +$8.09K 0.07% 83
2019
Q4
$224K Buy
+1,021
New +$224K 0.05% 79
2019
Q3
Sell
-1,162
Closed -$213K 87
2019
Q2
$213K Hold
1,162
0.06% 70
2019
Q1
$214K Sell
1,162
-108
-9% -$19.9K 0.07% 66
2018
Q4
$210K Hold
1,270
0.08% 60
2018
Q3
$244K Buy
1,270
+1,168
+1,145% +$224K 0.09% 53
2018
Q2
$17K Sell
102
-848
-89% -$141K 0.01% 268
2018
Q1
$155K Buy
+950
New +$155K 0.07% 72